Medicamen Organics Limited specializes in the development, manufacturing, and distribution of a diverse array of pharmaceutical dosages, including generic tablets, capsules, liquids, ointments, and more. They serve both governmental and private institutions as a contract manufacturer and are known for their B2B model. Their products have a significant presence in India and various international markets.

The company operates two approved manufacturing facilities in Uttarakhand, with a strong focus on quality control. They are ISO certified and maintain high safety standards. With a wide product portfolio of 84 items spanning various medical categories, Medicamen Organics has established itself as a reliable and innovative player in the pharmaceutical sector.

Key Objectives of the IPO:

  • Funding for international product registrations
  • Enhancing production capacity
  • Meeting working capital needs
  • General corporate purposes

Medicamen Organics IPO Details

Issue Opening and Closing Dates

The IPO is set to open on June 21, 2024 and close on June 25, 2024.

Financial Breakdown

IPO Size: Approx ₹10.54 Crores, 3,100,000 Equity Shares
Face Value: ₹10 Per Equity Share
IPO Price Band: ₹32 to ₹34 Per Equity Share
Listed On: NSE SME
Retail Quota: 35% of the net offer
QIB Quota: 50% of the net offer
NII Quota: 15% of the net offer
DRHP Draft Prospectus: Click Here
RHP Draft Prospectus: Click Here
Anchor Investors: Click Here

IPO Market Lot

The minimum market lot is 4000 shares with an application value of ₹136,000.

Application Lot Size Shares Amount
Retail Minimum 1 4000 ₹136,000
Retail Maximum 1 4000 ₹136,000
S-HNI Minimum 2 8000 ₹272,000

Upcoming IPO Dates

The IPO is scheduled to open on June 21, close on June 25, with allotment and listing on June 26 and June 28, 2024, respectively.

How to Apply for the IPO?

Investors can apply for the Medicamen Organics IPO through ASBA in their bank accounts or by downloading the IPO forms from the BSE website and submitting them either to a bank or a broker.

Analysis of Medicamen Organics Financials


Year Revenue (in Crores) Expense (in Crores)

Medicamen Organics IPO Valuation for FY2023

Here are the details of the Medicamen Organics IPO valuation for the financial year 2023, including key financial metrics:

Earning Per Share (EPS): ₹1.60 per Equity Share
Price/Earning P/E Ratio: [.]
Return on Net Worth (RoNW): 11.25%
Net Asset Value (NAV): ₹14.20 per Equity Share

Peer Group

Companies in the peer group of Medicamen Organics include:

  • Brooks Laboratories Ltd
  • Cian Healthcare Ltd
  • Zenotech Laboratories Ltd

Medicamen Organics IPO Registrar

The registrar for the Medicamen Organics IPO is Kfin Technologies Limited. Contact details:

Medicamen Organics IPO Allotment Status

Check the allotment status of the Medicamen Organics IPO on the Kfin Technologies website. Click Here

Medicamen Organics IPO Lead Managers

The lead managers for the Medicamen Organics IPO are:

  • GYR Capital Advisors Private Limited

Company Address

Contact details for Medicamen Organics Limited:

Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: [email protected] Website: Medicamen Organics Website

Medicamen Organics IPO FAQs

What is Medicamen Organics IPO?

Medicamen Organics IPO is an NSE SME IPO aiming to raise ₹10.54 Crores with an issue price range of ₹32 to ₹34 per equity share, set to be listed on NSE.